CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
The role of trastuzumab in the adjuvant setting
DOI 10.1055/s-2007-990339
Bibliografische Angaben
Nachweis in CareLit
Autor:innenE Matos, T Čufer
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Trastuzumab is a monoclone antibody directed against HER2 receptors that are overexpressed in approximately 20% of breast cancer patients. There were five clinical trials so far performed in which trastuzumab was applied in breast cancer patients in adjuvant setting. The results of all the trials consistently demonstrate a high efficacy of this target drug in the patients with HER2 positive tumors. So far, no formal…
Zitieren
Zitierempfehlung
E Matos, T Čufer (2007) The role of trastuzumab in the adjuvant setting. Senologie - Zeitschrift für Mammadiagnostik und -therapie (09). https://doi.org/10.1055/s-2007-990339
Mit CareLit weiterarbeiten